Allianz Asset Management »

Bicara Therapeutics shares owned by Allianz Asset Management

Quarter-by-quarter ownership of Bicara Therapeutics (BCAX) shares owned by Allianz Asset Management from 13F filings

Historical chart of Allianz Asset Management investment in Bicara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by Allianz Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by Allianz Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $511k 17k 29.69

More positions owned by Allianz Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Spdr Series Trust St Str P500etf (SPYM)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Venture Global Com Cl A (VG)
Alphabet Cap Stk Cl C (GOOG)
Micron Technology (MU)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Applied Materials (AMAT)
Lam Research Corp Com New (LRCX)
Johnson & Johnson (JNJ)

View all positions for Allianz Asset Management

Top funds holding Bicara Therapeutics

RA Capital Management
Siren
Vestal Point Capital
Deep Track Capital
BlackRock
Henderson Group
Jupiter Topco
Red Tree Management
Tpg Gp A
Vanguard Capital Management
Franklin Resources
FMR
Omega Fund Management
State Street Corporation
T. Rowe Price Associates

View all funds holding Bicara Therapeutics